Medicines Regulations




NEW ZEALAND GAZETTE, No. 77 — 3 AUGUST 2017

Restricted Medicines

Cyclizine; for oral use other than in medicines used for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 6 dosage units; for oral use in medicines used for the treatment of anxiety or insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

Ketoprofen; in solid dose form containing 25 milligrams or less per dose form in packs of not more than 30 capsules or tablets

Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health

Schedule 3

Pharmacy-only Medicines

Azelastine; in preparations for nasal use containing 0.15% azelastine hydrochloride or less; in topical eye preparations containing 0.05% or less

Bifonazole; for dermal use; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

Bilastine; in divided solid dosage forms for oral use containing 20 milligrams or less for the treatment of the symptoms of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria when sold in a pack containing not more than 30 dosage units

Esomeprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastro-oesophageal reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 7 dosage units

Lignocaine; for urethral use; for external use in medicines containing 10% or less and more than 2%

Loratadine; for oral use; except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply

Macrogols; in preparations for oral use as a liquid concentrate for laxative use

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in slow-release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack

Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia and hyperacidity or to be used on the recommendation of a registered medical practitioner when sold in the manufacturer’s original pack containing not more than 14 days’ supply; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

Medicines for General Sale

Please note that the following medicines are now available for general sale.

Albutrepenonacog alfa

Benzydamine; for oromucosal or topical use

Bifonazole; for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

Deoxycholic acid; for oral use

Efmoroctocog alfa

Lignocaine; in throat lozenges in medicines containing 30 milligrams or less per dose form; for external use in medicines containing 2% or less; in throat sprays in medicines containing 2% or less

Loratadine; in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply

Rurioctocog alfa pegol

Simoctocog alfa

Ranitidine; in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

48



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 77





✨ LLM interpretation of page content

🏥 Schedule 2 (continued from previous page)

🏥 Health & Social Welfare
Prescription Medicines, Schedule 2, Cyclizine, Ketoprofen, Levonorgestrel

🏥 Schedule 3

🏥 Health & Social Welfare
Pharmacy-only Medicines, Schedule 3, Azelastine, Bifonazole, Bilastine, Esomeprazole, Lignocaine, Loratadine, Macrogols, Paracetamol, Ranitidine

🏥 Medicines for General Sale

🏥 Health & Social Welfare
General Sale Medicines, Albutrepenonacog alfa, Benzydamine, Bifonazole, Deoxycholic acid, Efmoroctocog alfa, Lignocaine, Loratadine, Rurioctocog alfa pegol, Simoctocog alfa, Ranitidine